Study of Tesomet With Open-label Extension in Subjects With Prader-Willi Syndrome
Withdrawn before enrolling · Phase 2 · Has a placebo group
Conditions studied: Prader-Willi Syndrome
In brief
This study will evaluate the safety and efficacy of Tesomet (tesofensine + metoprolol) in subjects with PWS.
Key facts
- Study ID
- NCT05198362
- Run by
- Saniona
- People needed
- 0
- Starts
- 2021-12-28
- Expected to finish
- 2022-12-09
- Last updated by the study team
- 2022-12-13
Who can join
Age: 13 and older, up to 65. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Sparrow Clinical Research Institute — Lansing, Michigan, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.